{
    "paper_id": "PMC7232914",
    "metadata": {
        "title": "MHRA COVID-19 website for reporting ADRs and incidents",
        "authors": []
    },
    "body_text": [
        {
            "text": "The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has set up a website for reporting adverse drug reactions (ADRs) and equipment-related incidents in patients with COVID-19, in preparation for large-scale use of potential new or repurposed medicines, medical devices, diagnostic tests and future vaccines.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "COVID-19 Yellow Card reports will be used to monitor the safety of healthcare products being used in COVID-19 treatment, identify new or emerging risks, and take appropriate regulatory action, where necessary.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "\"I encourage healthcare professionals and patients to use our new dedicated site to report problems with medical equipment, including ventilators or testing kits, as well as any suspected side effects from medicines used to combat COVID-19,\" said Dr June Raine, Chief Executive of MHRA.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        }
    }
}